Alaunos Therapeutics, Inc. Share-based Payment Arrangement, Expense, Tax Benefit
Alaunos Therapeutics, Inc. (TCRT) reported Share-based Payment Arrangement, Expense, Tax Benefit of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-05.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2019-03-05
- Alaunos Therapeutics, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2018 was $0.00.
- Alaunos Therapeutics, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2017 was $0.00.
- Alaunos Therapeutics, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2016 was $0.00.
- Alaunos Therapeutics, Inc. share-based payment arrangement, expense, tax benefit for fiscal 2015 was $0.00.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-05 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-05 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-05 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |
| 2014-12-31 | $0.00 10-K · filed 2017-02-16 |
| 2013-12-31 | $0.00 10-K · filed 2016-02-24 |
| 2012-12-31 | $0.00 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |